HOME >> MEDICINE >> NEWS
Mount Sinai expands cutting-edge molecular testing

Today, Mount Sinai Hospital, announced that it has signed a three-year strategic alliance agreement with world-renowned diagnostic company Roche Diagnostics, to establish a Molecular Center of Excellence (MCOE). As a Roche designated MCOE, the Molecular Pathology Laboratory will offer physicians and patients the most advanced molecular diagnostics technologies such as Roche Diagnostics' patented Polymerase Chain Reaction (PCR), which is more sensitive and more specific than traditional diagnostic methods such as culture.

The Molecular Pathology Laboratory at Mount Sinai, through the leadership of Dr. David Zhang, has become nationally recognized for excellence in technology-based research and clinical molecular diagnostics. More than 6,000 medical laboratory tests are performed each year including 1) tests for infectious agents, such as Human Papiloma Virus and Epstein-Barr virus; 2) tests for genetic disorders, such as Factor V Leiden and Factor II (Prothrombin) gene mutation tests that provide fast and accurate tools to aid in the diagnosis and evaluation of patients with suspected thrombophilia; and 3) tumor oncology assays, such as tests for certain lymphocyte gene rearrangement which act as diagnostic markers for certain lymphomas and leukemias. These tests and other molecular diagnostics tests performed at Mount Sinai allow physicians to diagnose, treat and monitor diseases but most importantly, improve the lives of many patients seen at Mount Sinai.

"We are very excited to partner with Roche Diagnostics, a leader in the diagnostics industry," said David Zhang, MD, PhD, director of the Molecular Pathology Laboratory at Mount Sinai. "With the combination of Roche's cutting edge technologies and our expertise in clinical molecular diagnosis, we will be able to offer the most advanced diagnostic testing to Mount Sinai clinicians to assist with diagnosis, prescription and prognosis. The Molecular Pathology Laboratory has always strived for excel
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Jan-2006


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mountain bikers are cautioned to ride with care - major injuries do happen

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mount Sinai expands cutting edge molecular testing

(Date:4/23/2014)... Ritalin, may prevent the depletion of self-control, according to ... of the Association for Psychological Science. , Self-control can ... to focus attention on a boring textbook are hard ... for this difficulty: Exerting self-control for a long period ... on subsequent tasks. , "It is as if self-control ...
(Date:4/22/2014)... New Jersey Institute of Technology (NJIT) today to ... launch of the New Jersey Innovation Institute (NJII), ... for business innovation through the leveraging of industry, ... Senator Cory Booker, Panasonic Corp. of North America ... Governor Kim Guadagno, New Jersey Secretary of Higher ...
(Date:4/22/2014)... DALLAS April 22, 2014 Researchers at UT ... people suffering from depression . , A ... major mechanism by which ghrelin (a hormone with natural ... identified a potentially powerful new treatment for depression in ... , The study, published online in April,s ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... 2014. The latest scientific advances and emerging therapies in ... the main annual meeting of the Heart Failure Association ... will also hear breaking news on acute heart failure ... which is part of the main congress. , The ... at the Megaron Athens International Conference Centre (MAICC). The ...
Breaking Medicine News(10 mins):Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
(Date:1/14/2014)... York , January 14, 2014 ... System Transfer Devices (CSTD) for hazardous drugs, today announced that ... the fourth straight year.   Equashield,s ... pharmacy technicians, pharmacists, nurses and other medical professionals ...
(Date:1/14/2014)... 2014 Spark Therapeutics , a late-stage gene therapy company, ... program, a Phase 3 study for inherited retinal dystrophies caused by ... D. Marrazzo , is presenting this and other corporate updates today, ... San Francisco . Marrazzo said Spark was able to achieve ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
Cached News: